Hiteshkumar Natwarlal Suthar

Title: Hiteshkumar Natwarlal Suthar: Innovator in Pharmaceutical Development

Introduction

Hiteshkumar Natwarlal Suthar is a notable inventor based in Ahmedabad, India. His contributions to the field of pharmaceuticals have garnered attention, particularly in the development of innovative drug formulations.

Latest Patents

Hiteshkumar holds a patent for a process related to the preparation of apixaban, a crucial anticoagulant medication. The patent details a crystalline Form N-1 of apixaban that is substantially free from various impurities. Specifically, it focuses on compounds such as 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid and others, achieving a mean particle size equal to or greater than 100 micrometers.

Career Highlights

Hiteshkumar is currently associated with Cadila Healthcare Limited, a prominent pharmaceutical company known for its extensive research and development in healthcare solutions. His expertise in drug formulation has played a key role in advancing the company’s portfolio.

Collaborations

Throughout his career, Hiteshkumar has collaborated with distinguished colleagues such as Brij Khera and Kumar Kamlesh Singh. Their teamwork has contributed to various projects within the pharmaceutical domain, demonstrating the value of collaboration in innovation.

Conclusion

Hiteshkumar Natwarlal Suthar continues to make significant strides in pharmaceutical innovations. His work not only enhances the understanding of drug formulation but also contributes to the broader healthcare ecosystem, showcasing the impact of dedicated inventors in the industry.